Sotera Health Company (NASDAQ:SHC) held its 2026 annual meeting of stockholders on Thursday. Shareholders elected all four nominated Class III directors to serve three-year terms.
Richard G. Kyle received the highest number of votes in favor, with over 260 million shares voted for. Other directors elected include Sean L. Cunningham, Vincent K. Petrella, and Christopher A. Simon.
Shareholders also approved, on an advisory basis, the compensation of named executive officers, with over 257 million shares in favor.
The appointment of Ernst & Young LLP as independent auditor for fiscal year 2026 was ratified with over 267 million shares in favor.
Results were disclosed in a filing with the Securities and Exchange Commission.
